Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Ferric citrate[59Fe]7.4MBq/mL injection BP |
Is a |
Product containing iron-59 (medicinal product) |
false |
Inferred relationship |
Some |
|
|
Ferric citrate[59Fe]7.4MBq/mL injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ferric (59-Fe) citrate (substance) |
false |
Inferred relationship |
Some |
|
|
Ferric citrate[59Fe]7.4MBq/mL injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Iron radioisotope |
false |
Inferred relationship |
Some |
|
|
Ferric citrate[59Fe]7.4MBq/mL injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
agent radiopharmaceutique |
false |
Inferred relationship |
Some |
|
|
Ferric citrate[59Fe]7.4MBq/mL injection BP |
Has manufactured dose form |
injection |
false |
Inferred relationship |
Some |
|
|
Ferric citrate[59Fe]7.4MBq/mL injection BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Iron-59 (substance) |
false |
Inferred relationship |
Some |
|
|